Stenotrophomonas maltophilia is an emerging multidrug-resistant global opportunistic
pathogen. The increasing incidence of nosocomial and community-acquired S. maltophilia …

Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of
patients receiving mechanical ventilation (MV). In contrast to infections of more frequently …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

EXECUTIVE SUMMARY Since the initial 1996 American Thoracic Society (ATS) guideline
on nosocomial pneumonia, a number of new developments have appeared, mandating a …

ContextThe optimal duration of antimicrobial treatment for ventilator-associated pneumonia
(VAP) is unknown. Shortening the length of treatment may help to contain the emergence of …

This document is an update of the original 1993 statement on community-acquired
pneumonia, incorporating new information about bacteriology, patient stratification …

Inappropriate antibiotic use for pulmonary infiltrates is common in the intensive care unit
(ICU). We sought to devise an approach that would minimize unnecessary antibiotic use …

Pseudomonas aeruginosa is a leading cause of nosocomial infections. The risk of
emergence of antibiotic resistance may vary with different antibiotic treatments. To compare …

Abstract “Collateral damage” is a term used to refer to ecological adverse effects of antibiotic
therapy; namely, the selection of drug-resistant organisms and the unwanted development …

Pseudomonas aeruginosa is one of the leading causes of nosocomial infections. Severe
infections, such as pneumonia or bacteraemia, are associated with high mortality rates and …